{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "49702-255",
      "generic_name": "dolutegravir sodium",
      "labeler_name": "ViiV Healthcare Company",
      "brand_name": "Tivicay PD",
      "active_ingredients": [
        {
          "name": "DOLUTEGRAVIR SODIUM",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "49702-255-37",
          "description": "1 BOTTLE in 1 CARTON (49702-255-37)  / 60 TABLET, FOR SUSPENSION in 1 BOTTLE",
          "marketing_start_date": "20200612",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FOR SUSPENSION",
      "spl_id": "5037ffdb-75d0-4abb-bd21-0a1b5920042f",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200612",
      "product_id": "49702-255_5037ffdb-75d0-4abb-bd21-0a1b5920042f",
      "application_number": "NDA213983",
      "brand_name_base": "Tivicay PD",
      "pharm_class": [
        "HIV Integrase Inhibitors [MoA]",
        "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
        "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
        "Organic Cation Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}